Home - Translational Lung Cancer Research

Interviews with Outstanding Authors (2025)

In 2025, many authors make outstanding contributions to our journal. Their articles published with us have received very well feedback in the field and stimulate a lot of discussions and new insights among the peers.

Hereby, we would like to highlight some of our outstanding authors, with a brief interview of their thoughts and insights as authors. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

Reviewer of the Month (2025)

In 2025, TLCR reviewers continue to make outstanding contributions to the peer review process. They demonstrated professional effort and enthusiasm in their reviews and provided comments that genuinely help the authors to enhance their work.

Hereby, we would like to highlight some of our outstanding reviewers, with a brief interview of their thoughts and insights as a reviewer. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

TLCR Annual Report 2024

Welcome to the 2024 annual report for Translational Lung Cancer Research. In 2024, the TLCR has continued its mission to increase the quality and impact of the journal, and to provide readers with a novel, well-organized, informative, enlightening and educational journal.

We would like to sincerely thank our Editorial Board Members, Guest editors, Reviewers, Authors, Readers for all your supports and contributions to TLCR in 2024, and we look forward to continuing our work with you in the new year.

Interviews with Editorial Board Members

TLCR features a distinguished editorial board, the members of which continue to instill the power of their expertise for the journal’s development. By launching this column, we are glad to introduce to you some of them in the form of interviews, in which they will share their unique career experiences and perspectives. We believe their insights will shed light on the knowledge of related fields.

Interviews with Guest Editors

Over the years, a number of TLCR guest editors have made valuable contributions to the journal. This column features interviews with our guest editors, who graciously share their experience in scientific careers and provide insightful perspectives on the special series.

New Impact Factor for Translational Lung Cancer Research: 4

We are pleased to announce that the Translational Lung Cancer Research (TLCR) has attained its latest impact factor update for the 2023 citation year: 4.

Translational Lung Cancer Research 2023 CiteScore Released: 7.2

We are pleased to announce that the Translational Lung Cancer Research (TLCR) has received its 2023 CiteScore: 7.2, ranking 92 out of 404 journals in the Oncology category.

Furthermore, we are delighted to highlight the remarkable achievements made by all AME journals in the CiteScore ranking.

‹ ›

See full cover Image

Vol 14, No 5 (May, 2025)

Articles in Press

Past Issues

About tlcr

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

General editorial enquiries:
Email: editor@tlcr.org
Copyright related contact:
Email: permissions@amegroups.com
Commercial Sales contact (Reprints, advertising, etc.):
Email: sales@amegroups.com

Editorial

Pneumonectomy—a necessary evil?

Koen C. H. A. Verkoulen, Lars Geenen, Aimée J. P. M. Franssen, Lori M. van Roozendaal, Jean H. T. Daemen, Karel W. E. Hulsewé, Yvonne L. J. Vissers, Michel Gonzalez, Francesco Guerrera, Erik R. de Loos

PDF Pages: 1496-1499 Full Text (21) Peer Review File COI Form Open Access

Expert Consensus

Chinese expert consensus on shape-sensing robotic-assisted bronchoscopy (ssRAB) in the management of peripheral pulmonary lesions

Fangfang Xie, Chunxi Zhang, Chun Li, Dan Liu, Quncheng Zhang, Chuanyong Mu, Gang Hou, Manxiang Li, Chunli Tang, Fei Xu, Hong Chen, Zhongbo Chen, Ye Gu, Zhenbiao Guan, Cheng Ji, Haitao Li, Wei Li, Xuan Li, Yishi Li, Hairong Lian, Jiangrong Liao, Zhuang Luo, Haifeng Ouyang, Yongchun Shen, Yiwei Shi, Nansheng Wan, Tao Wang, Hong Wang, Huaqi Wang, Juan Wang, Jingxiang Wu, Xuemei Wu, Yang Xia, Kui Xiao, Wujian Xu, Huizhen Yang, Junyong Yang, Taosheng Ye, Xianwei Ye, Pengfei Yu, Nan Zhang, Peng Zhang, Qi Zhao, Xiaoxuan Zheng, Jun Zou, Enguo Chen, Hao Zhang, Jiayuan Sun; Professional Committee on Interventional Pulmonology of China Association for Promotion of Health Science and Technology; Expert Group on Technology of Shape-sensing Robotic assisted Bronchoscopy

PDF Pages: 1500-1515 Full Text (394) Peer Review File COI Form Open Access

Original Article

A Bayesian deep learning model with consolidation-to-tumor ratio (CTR) prior revolutionizes the prediction of spread through air spaces (STAS) in stage IA lung adenocarcinoma: a large-scale diagnostic study

Jie Cao, Nan Chen, Lingyu Zhou, Le Yi, Zhiyu Peng, Lin Qiu, Haokun Wu, Xiyue Tan, Kunhao Wu, Huahang Lin, Zhaokang Huang, Zetao Liu, Chenglin Guo, Xiuyuan Xu, Zhang Yi, Jiandong Mei

PDF Pages: 1516-1530 Full Text (32) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Clinicopathological factors vs. molecular model for predicting adjuvant EGFR-TKI benefit in stage I EGFR-mutant non-small cell lung cancer

Yu Jiang, Yuechun Lin, Wenhai Fu, Si Jiang, Zhexue Hao, Hengrui Liang, Qihua He, Ran Cheng, Bingliang Li, Hongsheng Deng, Caichen Li, Jianfu Li, Shan Xiong, Ran Zhong, Songan Chen, Wei Wang, Jianxing He, Wenhua Liang

PDF Pages: 1531-1542 Full Text (29) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Absent preoperative non-small cell lung cancer confirmation and relevant stage migration in the era before neoadjuvant chemoimmunotherapy: implications for treatment decisions in resectable non-small cell lung cancer

Guus R. M. van den Heuvel, Bas L. R. Mandos, Olga C. J. Schuurbiers, Francesco Ciompi, Erik Aarntzen, Kaamar Azijli, Iris Walraven, Hans J. M. Smit, Michel M. van den Heuvel

PDF Pages: 1543-1557 Full Text (22) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Outcomes of chemotherapy with or without immunotherapy in older patients with non-small cell lung cancer and low PD-L1 expression

Hayato Kawachi, Tae Hata, Tadaaki Yamada, Yasuhiro Goto, Akihiko Amano, Yoshiki Negi, Satoshi Watanabe, Naoki Furuya, Tomohiro Oba, Tatsuki Ikoma, Akira Nakao, Keiko Tanimura, Hirokazu Taniguchi, Akihiro Yoshimura, Tomoya Fukui, Daiki Murata, Kyoichi Kaira, Shinsuke Shiotsu, Makoto Hibino, Asuka Okada, Yusuke Chihara, Takashi Kijima, Koichi Takayama

PDF Pages: 1558-1568 Full Text (20) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Prognostic factors of liver metastases in extensive-stage small cell lung cancer receiving chemo-immunotherapy

Kyoichi Kaira, Yuhei Kurata, Hisao Imai, Ayako Shiono, Yu Miura, Kosuke Hashimoto, Ou Yamaguchi, Atusto Mouri, Hiroshi Kagamu

PDF Pages: 1569-1581 Full Text (24) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Change of bone mineral density as a prognostic marker in small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study

Weiwei Liu, Yusheng Guo, Peng Mo, Jie Lou, Bingxin Gong, Xiaona Fu, Yi Li, Kailu Zhang, Yi Ren, Shanshan Jiang, Peng Sun, Junping Li, Yong Wang, Lian Yang

PDF Pages: 1582-1595 Full Text (24) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Attention mechanism-based habitat analysis for predicting pleural invasion and prognosis of pulmonary nodules

Wei Zhang, Xiangfeng Gan, Wenzeng Chen, Xiaohui Duan, Zhuojian Shen, Haohua Xu, Honglue Dai, Ju Chen, Baishen Chen

PDF Pages: 1596-1610 Full Text (36) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Radial endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA) enhances diagnostic yield in pulmonary nodule biopsy

Rong Lih Ho, Joong Hyun Ahn, Jung Ho Han, Junsu Choe, Sun Hye Shin, Byeong-Ho Jeong, Sang-Won Eom, Hojoong Kim, Kyungjong Lee

PDF Pages: 1611-1621 Full Text (68) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Ivonescimab plus chemotherapy in advanced or metastatic non‐squamous non‐small cell lung cancer with EGFR variant in China: a cost‐effectiveness analysis

Rong Long, Weilu Kuang, Qin Zhou

PDF Pages: 1622-1634 Full Text (30) Reporting Checklist Peer Review File COI Form Open Access

Pattern-based volumetric CT quantification to predict radiation pneumonitis in patients with non-small-cell lung cancer who have diffuse parenchymal lung disease

Jonghoon Kim, Min Hwan Kwak, Jae Myoung Noh, You Jin Oh, Hongseok Yoo, Hye Jeon Hwang, Joon Beom Seo, Sung Goo Park, Hong Ryull Pyo, Ho Yun Lee

PDF Pages: 1635-1649 Full Text (Video) (40) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Re-irradiation for local recurrence after definitive stereotactic body radiotherapy for early-stage non-small cell lung cancer

Taiki Takaoka, Natsuo Tomita, Chisa Hashizume, Takahiko Tsugawa, Akira Torii, Dai Okazaki, Masanari Niwa, Nozomi Kita, Masanosuke Oguri, Seiya Takano, Masahiro Sasaguchi, Machiko Ukai, Yasutaka Ogawa, Akio Niimi, Akio Hiwatashi

PDF Pages: 1650-1659 Full Text (34) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Impaired natural killer cell maturation in lung adenocarcinoma driven by FABP4 and SPON2 downregulation through disrupted lipid metabolism

Hongxia Tian, Kezhen Li, Jing Chen, Weibang Guo, Zepeng Guo, Shuilian Zhang, Zhi Xie, Xin Huang, Sipei Wu, Wenzhao Zhong

PDF Pages: 1660-1676 Full Text (16) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Impact of coronavirus disease 2019 on surgery in patients with early-stage lung cancer: the COVIDLungSurg prospective cohort study

Zhenyi Niu, Feng Zhu, Yuqin Cao, Congcong Luo, Dan Liu, Chunping Wang, Zhenbin Qiu, Lishan Peng, Mingyuan Du, Runsen Jin, Yan Yan, Dong Dong, Hui Jing, Xiaofeng Wang, Wei Guo, Zengya Guo, Chengqiang Li, Dingpei Han, Yajie Zhang, Jie Xiang, Hailei Du, Kai Chen, Zhengxin Yin, Jie Yang, Wenzhao Zhong, Yongxin Zhou, Mingsong Wang, Dongchun Ma, Hecheng Li

PDF Pages: 1677-1687 Full Text (21) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Evaluating the tumor response assessment of modified-RECIST 1.1 in advance non-small cell lung cancer: a post-hoc analysis of 1,147 patients from the EAST-LC trial

Qun Chen, Wenwen Huang, Gang Chen, Huaqiang Zhou, Jing Luo, Yuanyuan Zhao, Yan Huang, Yunpeng Yang, Wenfeng Fang, Ting Zhou, Yuxiang Ma, Li Zhang, Hongyun Zhao

PDF Pages: 1688-1698 Full Text (36) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Different prognosis of multiple lung cancer identified by 116-gene panel by next-generation sequencing based on an Asian population

Chen-Hui Ni, Mu-Ting Wang, Ping-Hua Lin, Yan-Qi Lu, Yi-Peng Chen, Wei Zheng, Yuan-Zhong Chen, Chang-Ping Yang, Chun Chen, Bin Zheng

PDF Pages: 1699-1714 Full Text (19) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Oral microbiome and risk of lung cancer: results from a two-sample mendelian randomization analysis

Chudong Wang, Biao Hu, Qiuyi Liang, Han Jiang, Lu Yuan, Shuben Li

PDF Pages: 1715-1723 Full Text (30) Reporting Checklist Peer Review File COI Form Open Access

Combination of immune checkpoint inhibitors with multi-targeted tyrosine kinase inhibitors for second- or later-line therapy of non-small cell lung cancer: a systematic review and meta-analysis

Wujian Xu, Ximing Liao, Kun Wang, Ting Shi

PDF Pages: 1724-1739 Full Text (19) Reporting Checklist Peer Review File COI Form Open Access

Construction of a checkpoint inhibitor-related pneumonia diagnostic model based on exhaled nitric oxide: a prospective observational study

Yimei Gao, Tingyue Luo, Danhui Huang, Zeyu Fu, Shudong Ma, Li Lin, Haohua Huang, Tiantian Liu, Jinming Zhang, Xiaoxiao Jiang, Yanmei Ye, Junwei Chen, Junjie Xi, Jinzhong Zhuo, Kaijun Chen, Jingqi Ai, Laiyu Liu, Shaoxi Cai, Hangming Dong

PDF Pages: 1740-1755 Full Text (20) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Deep learning in histopathology images for prediction of oncogenic driver molecular alterations in lung cancer: a systematic review and meta-analysis

Rafael Parra-Medina, Gabriela Guerron-Gomez, Daniel Mendivelso-González, Javier Hernan Gil-Gómez, Juan Pablo Alzate, Marcela Gomez-Suarez, Jose Fernando Polo, John Jaime Sprockel, Andres Mosquera-Zamudio

PDF Pages: 1756-1769 Full Text (35) Reporting Checklist Peer Review File COI Form Open Access

Impact of omitting clinical target volume in radiotherapy for locally advanced non-small cell lung cancer: a propensity score matching analysis

Liang Liu, Wen Bao, Xiaoshuai Yuan, Yaoyao Zhu, Ying Zhang, Petros Christopoulos, Baptiste Abbar, Cheng Qian, Shuangyan Yang, Yaping Xu

PDF Pages: 1770-1785 Full Text (21) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

One-year mortality risk prediction model for patients with interstitial lung disease and lung cancer

Xiaorui Ding, Wanqing Zhou, Guanning Zhong, Ranxun Chen, Qingqing Xu, Lulu Chen, Yingwei Zhang, Yi Zhuang, Liyun Miao, Jinghong Dai

PDF Pages: 1786-1803 Full Text (18) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Comparative effectiveness of pembrolizumab-chemotherapy versus chemotherapy with/without bevacizumab in unresectable, locally advanced or metastatic non-small cell lung cancer: a Chinese multicenter real-world analysis emphasizing PD-L1-negative populations

Xiaobei Guo, Hui Zhang, Yuequan Shi, Qi He, Anwen Liu, Zhimin Zeng, Jinghui Wang, Song Wei, Tong Zhang, Cuimin Ding, Jian Fang, Xiaoling Chen, Paul Van Schil, Haoran Zhang, Junyi Pang, Minjiang Chen, Jing Zhao, Wei Zhong, Zhen Huo, Yan Xu, Mengzhao Wang

PDF Pages: 1804-1820 Full Text (20) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Review Article

Surgery without distance: will 5G-based robot-assisted telesurgery redefine modern surgery?

Xin Xie, Yu Tian, Jia Huang, Qingquan Luo, Tianxiang Chen

PDF Pages: 1821-1829 Full Text (18) Peer Review File COI Form Open Access

Opportunities and challenges in lung cancer care in the era of large language models and vision language models

Yi Luo, Hamed Hooshangnejad, Wilfred Ngwa, Kai Ding

PDF Pages: 1830-1847 Full Text (20) Peer Review File COI Form Open Access

Impacts of co-mutations in oligometastatic and oligoprogressive non-small cell lung cancer with EGFR/ALK mutations—a narrative review of the current literature

Jeong Uk Lim, Ae Lee Jang, Jayoung Lee, Sonya Youngju Park, Tai Joon An, Young Jo Sa, Hyo Rim Kim, Tae-Jung Kim, Byoung Hyuck Kim, Chan Kwon Park

PDF Pages: 1848-1861 Full Text (22) Reporting Checklist Peer Review File COI Form Open Access

Case Report

Visceral crisis in a patient with non-small cell lung cancer and ROS1::SDC4 fusion: intrinsic resistance to entrectinib via L2026M mutation—a case report

Vaneza Avila Rodriguez, Nicolle Wagner-Gutiérrez, Jairo Andrés Zuluaga León, Leonardo Rojas, Lucia Viola, Stella Isabel Martínez Jaramillo, Carlos Andrés Carvajal Fierro, Alejandro Ruiz-Patiño, Oscar Arrieta, Luis Corrales, Claudio Martin, Andrés F. Cardona

PDF Pages: 1862-1869 Full Text (36) Reporting Checklist Peer Review File COI Form Open Access

Neoadjuvant tepotinib in stage IIB N0 non-small cell lung carcinoma with MET exon 14 skipping mutation: a case report and review of the literature

Amanda Reyes, Rebecca Pharaon, Atish Mohanty, Jae Kim, Erminia Massarelli

PDF Pages: 1870-1876 Full Text (15) Reporting Checklist Peer Review File COI Form Open Access

Editorial Commentary

Emotional distress: the hidden barrier to immunotherapy success in advanced non-small cell lung cancer

Shannon Zhang, Shiyao Wang, Zhaohui Liao Arter

PDF Pages: 1877-1881 Full Text (10) Peer Review File COI Form Open Access

Perioperative immunochemotherapy in stage IIIA non-small cell lung cancer: insights on the path forward

Junichi Soh

PDF Pages: 1882-1886 Full Text (18) Peer Review File COI Form Open Access

Sacituzumab govitecan: a new hope for patients with pretreated extensive small-cell lung cancer (SCLC)—insights from the TROPiCS-03 trial

Baptiste Abbar, Frank Aboubakar Nana, Jean Philippe Spano, Jacques Cadranel, Paul Gougis

PDF Pages: 1887-1891 Full Text (22) Peer Review File COI Form Open Access

Review Articles

Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?

Yoshihisa Kobayashi, Tetsuya Mitsudomi

Published online: 22 October 2013

PDF Pages: 354-363 Full Text (338573) Open Access

Editorial Commentary

Ground glass nodules with 5 years’ stability can grow after 10-year follow-up: do genetic features determine the fate?

Yoshihisa Kobayashi, Tetsuya Mitsudomi

Published online: 31 December 2019

PDF Pages: S425-S427 Full Text (84576) Open Access

Review Article

Non-small cell lung cancer: current treatment and future advances

Cecilia Zappa, Shaker A. Mousa

Published online: 30 June 2016

PDF Pages: 288-300 Full Text (77790) Open Access

Review Articles

Irreversible EGFR-TKIs: dreaming perfection

Lorenza Landi, Federico Cappuzzo

Published online: 14 January 2013

PDF Pages: 40-49 Full Text (70189) Open Access

Review Article

Pulmonary ground-glass opacity: computed tomography features, histopathology and molecular pathology

Jian-Wei Gao, Stefania Rizzo, Li-Hong Ma, Xiang-Yu Qiu, Arne Warth, Nobuhiko Seki, Mizue Hasegawa, Jia-Wei Zou, Qian Li, Marco Femia, Tang-Feng Lv, Yong Song, written on behalf of the AME Lung Cancer Collaborative Group

Published online: 28 February 2017

PDF Pages: 68-75 Full Text (59688) Open Access

Review Article

Recurrence after surgery in patients with NSCLC

Hidetaka Uramoto, Fumihiro Tanaka

Published online: 28 August 2014

PDF Pages: 242-249 Full Text (47428) Open Access

Review Article

Targeted therapy for non-small cell lung cancer: current standards and the promise of the future

Bryan A. Chan, Brett G.M. Hughes

Published online: 24 February 2015

PDF Pages: 36-54 Full Text (43145) Open Access

Review Article

Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment

Tianli Zhang, Bing Wan, Yuan Zhao, Chuling Li, Hongbing Liu, Tangfeng Lv, Ping Zhan, Yong Song

Published online: 30 June 2019

PDF Pages: 302-316 Full Text (42913) Open Access

Review Article

Lung cancer prediction using machine learning and advanced imaging techniques

Timor Kadir, Fergus Gleeson

Published online: 14 June 2018

PDF Pages: 304-312 Full Text (42876) Open Access

Review Article

The past, present and future of immunotherapy against tumor

Tao Jiang, Caicun Zhou

Published online: 24 June 2015

PDF Pages: 253-264 Full Text (39456) Open Access

Review Article

Ground-glass nodules of the lung in never-smokers and smokers: clinical and genetic insights

Yoshihisa Kobayashi, Chiara Ambrogio, Tetsuya Mitsudomi

Published online: 28 August 2018

PDF Pages: 487-497 Full Text (37744) Chinese (5425) Open Access

Review Article

The epidemiology of lung cancer

Patricia M. de Groot, Carol C. Wu, Brett W. Carter, Reginald F. Munden

Published online: 14 June 2018

PDF Pages: 220-233 Full Text (33958) Open Access

Review Article

Lung cancer screening: nodule identification and characterization

Ioannis Vlahos, Konstantinos Stefanidis, Sarah Sheard, Arjun Nair, Charles Sayer, Joanne Moser

Published online: 14 June 2018

PDF Pages: 288-303 Full Text (33036) Open Access

Review Articles

KRAS mutant NSCLC, a new opportunity for the synthetic lethality therapeutic approach

Javier de Castro Carpeño, Cristóbal Belda-Iniesta

Published online: 03 April 2013

PDF Pages: 142-151 Full Text (32387) Open Access

Review Article

Molecular testing strategies in non-small cell lung cancer: optimizing the diagnostic journey

Jeffrey P. Gregg, Tianhong Li, Ken Y. Yoneda

Published online: 30 June 2019

PDF Pages: 286-301 Full Text (32082) Open Access

Review Article on Update on Pathology and Predictive Biomarkers of Lung Cancer

Biology of invasive mucinous adenocarcinoma of the lung

Yoon Jin Cha, Hyo Sup Shim

Published online: 11 October 2017

PDF Pages: 508-512 Full Text (32044) Open Access

Consensus

Tubeless video-assisted thoracic surgery for pulmonary ground-glass nodules: expert consensus and protocol (Guangzhou)

Jianxing He, Hengrui Liang, Wei Wang, Andrey Akopov, Alberto Aiolfi, Keng-Leong Ang, Luca Bertolaccini, Kaican Cai, Qingdong Cao, Baojun Chen, Chang Chen, Chun Chen, Donglai Chen, Fengxia Chen, Jun Chen, Lei Chen, Mingwu Chen, Yongbing Chen, Zhuxing Chen, Chao Cheng, Dong Cui, Fei Cui, Tianyang Dai, Qinglong Dong, Paolo A. Ferrari, Raja M. Flores, Junke Fu, Soichiro Funaki, Marios E. Froudarakis, Xiangfeng Gan, Mingfei Geng, Jialong Guo, Qiang Guo, Yongtao Han, Jintao He, Kaiming He, Kyoji Hirai, Jian Hu, Shuqiao Hu, Jian Huang, Jun Huang, Wenfa Jiang, Kyung Soo Kim, Gabor Kiss, Fanyi Kong, Lan Lan, Xuefeng Leng, Bin Li, Gaofeng Li, Hecheng Li, Hefei Li, Heng Li, Jiwei Li, Xiaoqiang Li, Shuben Li, Yinfen Li, Zhuoyi Li, Yi Liang, Lixia Liang, Wenhua Liang, Yongde Liao, Wanli Lin, Xu Lin, Hongxu Liu, Hui Liu, Jixian Liu, Jun Liu, Xiang Liu, Zihao Liu, Xingzhao Lu, Qingquan Luo, Naiquan Mao, Qi Pan, Dazhi Pang, Jun Peng, Jun Peng, Eugenio Pompeo, Rulin Qian, Kun Qiao, Bassam Redwan, Zi Sang, Wenlong Shao, Jianfei Shen, Weiyu Shen, Sook-Whan Sung, Wenfang Tang, Tianhu Wang, Guangsuo Wang, Haitao Wang, Huien Wang, Jiyong Wang, Wen Wang, Yongyong Wang, Zhenyuan Wang, Li Wei, Wei Wei, Hao Wu, Jie Wu, Zhaohua Xia, Chenyang Xu, Enwu Xu, Hai Xu, Ning Xu, Quan Xu, Rongyu Xu, Shun Xu, Chaokun Yang, Hanyu Yang, Shengli Yang, Jun Yi, Guangjian Zhang, Hao Zhang, Jia Zhang, Man Zhang, Xiao Zhang, Yajie Zhang, Zhe Zhang, Zhifeng Zhang, Honglin Zhao, Jian Zhao, Xiaodong Zhao, Jianping Zhou, Yanran Zhou, Chengchu Zhu, Shaojin Zhu, Xinhai Zhu, Jian Cui, Yubo Yan, Ke-Neng Chen

Published online: 28 August 2021

PDF Pages: 3503-3519 Full Text (30329) COI Form Open Access

Review Article

Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer

Takashi Kohno, Takashi Nakaoku, Koji Tsuta, Katsuya Tsuchihara, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto

Published online: 19 April 2015

PDF Pages: 156-164 Full Text (29325) Open Access

Review Articles

New TNM classification: achievements and hurdles

Peter Goldstraw

Published online: 17 August 2013

PDF Pages: 264-272 Full Text (28933) Open Access

Review Articles

Angiogenesis in cancer: anti-VEGF escape mechanisms

Gerald W. Prager, Marina Poettler, Matthias Unseld, Christoph C. Zielinski

Published online: 18 February 2012

PDF Pages: 14-25 Full Text (28816) Open Access

Full Most Read article list >>

Original Article

Prognostic value of Twist in lung cancer: systematic review and meta-analysis

Junli Zeng, Ping Zhan, Guannan Wu, Wen Yang, Wenjun Liang, Tangfeng Lv, Yong Song

BRAF mutations in non-small cell lung cancer

Peter P. Luk, Bing Yu, Chiu Chin Ng, Belinda Mercorella, Christina Selinger, Trina Lum, Steven Kao, Sandra A. O’Toole, Wendy A. Cooper

The suitability of small biopsy and cytology specimens for EGFR and other mutation testing in non-small cell lung cancer

Shu Wang, Bing Yu, Chiu Chin Ng, Belinda Mercorella, Christina I. Selinger, Sandra A. O’Toole, Wendy A. Cooper

Itraconazole can inhibit malignant pleural effusion by suppressing lymphangiogenesis in mice

Yunfen Wang, Yanwen Yao, Hongbin Liu, Xingqun Ma, Tangfeng Lv, Dongmei Yuan, Xinwu Xiao, Jie Yin, Yong Song

Ratio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer

Fangfang Chen, Yanwen Yao, Chunyan Ma, Xingqun Ma, Zhaofeng Wang, Tangfeng Lv, Xinwu Xiao, Jie Yin, Yong Song

Advanced proton beam dosimetry part II: Monte Carlo vs. pencil beam-based planning for lung cancer

Dominic Maes, Jatinder Saini, Jing Zeng, Ramesh Rengan, Tony Wong, Stephen R. Bowen

The cytokinesis-blocked micronucleus assay as a novel biomarker for selection of lung cancer screening participants

Randa A. El-Zein, Carol J. Etzel, Reginald F. Munden

The use of TCP based EUD to rank and compare lung radiotherapy plans: in-silico study to evaluate the correlation between TCP with physical quality indices

Abdulhamid Chaikh, Jacques Balosso

Review Article

Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer

Takashi Kohno, Takashi Nakaoku, Koji Tsuta, Katsuya Tsuchihara, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto

Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement

Hyojin Kim, Jin-Haeng Chung

Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer

Haoran Zhai, Wenzhao Zhong, Xuening Yang, Yi-Long Wu

Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations—a review

Erin L. Stewart, Samuel Zhixing Tan, Geoffrey Liu, Ming-Sound Tsao

Clinical trials for lung cancer in China

Fei-Yu Niu, Wen-Zhao Zhong, Qing Zhou, Yi-Long Wu

Recurrence after surgery in patients with NSCLC

Hidetaka Uramoto, Fumihiro Tanaka

Prognostic markers in lung cancer: is it ready for prime time?

Chang-Qi Zhu, Ming-Sound Tsao

Potential biomarkers for lung cancer screening

Gabriella Sozzi, Mattia Boeri

Particle therapy in non-small cell lung cancer

Zhongxing Liao, Charles B. Simone II

Computer Aided Nodule Analysis and Risk Yield (CANARY) characterization of adenocarcinoma: radiologic biopsy, risk stratification and future directions

Ryan Clay, Srinivasan Rajagopalan, Ronald Karwoski, Fabien Maldonado, Tobias Peikert, Brian Bartholmai

Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancer

Neil K. Taunk, Andreas Rimner, Melissa Culligan, Joseph S. Friedberg, Julie Brahmer, Jamie Chaft

Combining immunotherapy and radiation therapy for small cell lung cancer and thymic tumors

Suchit H. Patel, Andreas Rimner, Roger B. Cohen

Intraoperative near-infrared imaging of mesothelioma

Gregory Thomas Kennedy, Andrew Newton, Jarrod Predina, Sunil Singhal

BAP1, a tumor suppressor gene driving malignant mesothelioma

Mitchell Cheung, Joseph R. Testa

Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation

Jonathan E. Schoenhals, Steven N. Seyedin, Clark Anderson, Eric D. Brooks, Yun R. Li, Ahmed I. Younes, Sharareh Niknam, Ailin Li, Hampartsoum B. Barsoumian, Maria Angelica Cortez, James W. Welsh

Diagnostic and prognostic biomarkers for malignant mesothelioma: an update

Zhongjian Chen, Giovanni Gaudino, Harvey I. Pass, Michele Carbone, Haining Yang

Immunotherapy for malignant pleural mesothelioma: current status and future directions

Jordan Dozier, Hua Zheng, Prasad S. Adusumilli

Biology and clinical significance of circulating tumor cell subpopulations in lung cancer

Linda O’Flaherty, Harriet Wikman, Klaus Pantel

Routine clinical use of circulating tumor cells for diagnosis of mutations and chromosomal rearrangements in non-small cell lung cancer—ready for prime-time?

Emma Pailler, Vincent Faugeroux, Marianne Oulhen, Cyril Catelain, Françoise Farace

Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer

Sumitra Mohan, Francesca Chemi, Ged Brady

Biophysical technologies for understanding circulating tumor cell biology and metastasis

Derrick W. Su, Jorge Nieva

Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer

Marianna Gallo, Antonella De Luca, Monica Rosaria Maiello, Amelia D’Alessio, Claudia Esposito, Nicoletta Chicchinelli, Laura Forgione, Maria Carmela Piccirillo, Gaetano Rocco, Alessandro Morabito, Gerardo Botti, Nicola Normanno

Integrating immunotherapy into chemoradiation regimens for medically inoperable locally advanced non-small cell lung cancer

Salma K. Jabbour, Abigail T. Berman, Charles B. Simone II

Editorial

An alternative way to initiate Notch1 signaling in non-small cell lung cancer

Yi-Lin Yang, David Jablons, Liang You

Combination MET- and EGFR-directed therapy in MET-overexpressing non-small cell lung cancers: time to move on to better biomarkers?

Fernando C. Santini, Siddharth Kunte, Alexander Drilon

Systematic Review and Meta-analysis

Association of the metformin with the risk of lung cancer: a meta-analysis

Li Wang, Yong Song, Guan-Nan Wu, Dong-Mei Yuan

China Lung Cancer Research Highlight

Dll4/Notch1 signaling from tip/stalk endothelial cell specification to stroma-dependent lung tumor inhibition: a flavor of Dll4/Notch1 pleiotropy in tumor cell biology

Maria Felice Brizzi, Paola Defilippi

Editorials

Dulanermin in cancer therapy: Still much to do

Cristina Quintavalle, Gerolama Condorelli

Review Articles

EGFR molecular testing in African-American non-small cell lung cancer patients - a review of discrepant data

Bradley T. Clifford, Pingfu Fu, Nathan A. Pennell, Balazs Halmos, Rom S. Leidner

Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung

Pedro Mendez, Jose Luis Ramirez

Role of HGF/MET axis in resistance of lung cancer to contemporary management

Kanwal Pratap Singh Raghav, Ana Maria Gonzalez-Angulo, George R. Blumenschein Jr

Circulating soluble intercellular adhesion Molecule-1 in lung cancer: a systematic review

Xiaoling Gu, Chunyan Ma, Dongmei Yuan, Yong Song

Ceritinib

Clinical development and approval of second generation ALK inhibitors for ALK rearranged lung cancer

Daniel B. Costa

Onartuzumab plus erlotinib

Targeting MET in NSCLC: looking for a needle in a haystack

Lorenza Landi, Federico Cappuzzo

Nivolumab

Nivolumab (anti-PD-1, BMS-936558, ONO-4538) in patients with advanced non-small cell lung cancer

Arun Rajan, James L. Gulley

Brief Report

The role of Imaging and Radiation Oncology Core for precision medicine era of clinical trial

Ying Xiao, Mark Rosen

Review Article on Update on Pathology and Predictive Biomarkers of Lung Cancer

Biology of invasive mucinous adenocarcinoma of the lung

Yoon Jin Cha, Hyo Sup Shim

Immunohistochemistry for predictive biomarkers in non-small cell lung cancer

Mari Mino- Kenudson

Below are the latest Translational Lung Cancer Research articles published online ahead of print publication.

Currently no content available!

Journal Highlight more

Translational Lung Cancer Research is an international, peer-reviewed, open-access journal indexed by Science Citation Index Expanded (SCIE) and PubMed/PubMed Central, focusing on cutting-edge development on the transition from preclinical to clinical research, including but not limited to multimodality therapy, markers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to lung cancer and relevant thoracic diseases.